ERBB4 and neoplasm: Considering all the patients showing downregulation of total HER4 in their tumor tissue, in 82% of these NRG4 was also downregulation and in 86% one or more of the EGFR-shared ligands (HB-EGF, epiregulin, betacellulin) was upregulated.